Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shenhuang San is a Traditional Chinese Medicine (TCM) formulation primarily composed of *Panax ginseng* (Ginseng) and *Rheum palmatum* (Rhubarb). It is widely utilized in clinical practice in China, particularly as a hospital-made preparation, for the management of postoperative gastrointestinal dysfunction and intestinal obstruction. The formula is frequently administered as a topical paste applied to the umbilical region (Shenque point) to stimulate bowel movements and promote the recovery of gastrointestinal motility. In the field of oncology, Shenhuang San is investigated for its potential to enhance immune function and improve the quality of life in patients undergoing chemotherapy for gastrointestinal malignancies, such as gastric and colorectal cancers. Its pharmacological effects are attributed to the synergistic action of ginsenosides and anthraquinones, which modulate enteric nervous system activity and systemic inflammatory responses.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on shenhuang san.